Annual Cash & Cash Equivalents
$5.71 M
-$14.58 M-71.84%
December 31, 2023
Summary
- As of February 7, 2025, XTNT annual cash & cash equivalents is $5.71 million, with the most recent change of -$14.58 million (-71.84%) on December 31, 2023.
- During the last 3 years, XTNT annual cash & cash equivalents has risen by +$3.37 million (+144.13%).
- XTNT annual cash & cash equivalents is now -71.84% below its all-time high of $20.30 million, reached on December 31, 2022.
Performance
XTNT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$6.60 M
+$1.22 M+22.63%
September 30, 2024
Summary
- As of February 7, 2025, XTNT quarterly cash and cash equivalents is $6.60 million, with the most recent change of +$1.22 million (+22.63%) on September 30, 2024.
- Over the past year, XTNT quarterly cash and cash equivalents has dropped by -$2.07 million (-23.87%).
- XTNT quarterly cash and cash equivalents is now -67.53% below its all-time high of $20.31 million, reached on June 30, 2021.
Performance
XTNT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
XTNT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -71.8% | -23.9% |
| 3 y3 years | +144.1% | -63.7% |
| 5 y5 years | -15.9% | +14.7% |
XTNT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -71.8% | at low | -67.5% | +59.4% |
| 5 y | 5-year | -71.8% | +144.1% | -67.5% | +181.8% |
| alltime | all time | -71.8% | >+9999.0% | -67.5% | >+9999.0% |
Xtant Medical Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.60 M(+22.6%) |
| Jun 2024 | - | $5.38 M(+18.3%) |
| Mar 2024 | - | $4.55 M(-20.4%) |
| Dec 2023 | $5.71 M(-71.8%) | $5.71 M(-34.0%) |
| Sep 2023 | - | $8.66 M(+109.4%) |
| Jun 2023 | - | $4.14 M(-20.1%) |
| Mar 2023 | - | $5.18 M(-74.5%) |
| Dec 2022 | $20.30 M(+11.3%) | $20.30 M(+16.9%) |
| Sep 2022 | - | $17.36 M(+5.3%) |
| Jun 2022 | - | $16.50 M(-2.1%) |
| Mar 2022 | - | $16.85 M(-7.6%) |
| Dec 2021 | $18.24 M(+679.3%) | $18.24 M(+0.4%) |
| Sep 2021 | - | $18.18 M(-10.5%) |
| Jun 2021 | - | $20.31 M(+9.0%) |
| Mar 2021 | - | $18.64 M(+696.4%) |
| Dec 2020 | $2.34 M(-55.3%) | $2.34 M(-14.6%) |
| Sep 2020 | - | $2.74 M(-9.2%) |
| Jun 2020 | - | $3.02 M(-6.8%) |
| Mar 2020 | - | $3.24 M(-38.2%) |
| Dec 2019 | $5.24 M(-23.0%) | $5.24 M(-8.9%) |
| Sep 2019 | - | $5.75 M(-21.4%) |
| Jun 2019 | - | $7.32 M(+3.1%) |
| Mar 2019 | - | $7.10 M(+4.4%) |
| Dec 2018 | $6.80 M(+138.0%) | $6.80 M(+34.2%) |
| Sep 2018 | - | $5.06 M(-16.3%) |
| Jun 2018 | - | $6.05 M(-2.0%) |
| Mar 2018 | - | $6.17 M(+116.1%) |
| Dec 2017 | $2.86 M(+10.8%) | $2.86 M(+38.0%) |
| Sep 2017 | - | $2.07 M(+24.3%) |
| Jun 2017 | - | $1.66 M(-33.1%) |
| Mar 2017 | - | $2.49 M(-3.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $2.58 M(-59.5%) | $2.58 M(+83.0%) |
| Sep 2016 | - | $1.41 M(-36.5%) |
| Jun 2016 | - | $2.22 M(-52.5%) |
| Mar 2016 | - | $4.67 M(-26.7%) |
| Dec 2015 | $6.37 M(+42.5%) | $6.37 M(-20.1%) |
| Sep 2015 | - | $7.97 M(+293.4%) |
| Jun 2015 | - | $2.03 M(-30.1%) |
| Mar 2015 | - | $2.90 M(-35.1%) |
| Dec 2014 | $4.47 M(+46.7%) | $4.47 M(-35.7%) |
| Sep 2014 | - | $6.95 M(+132.6%) |
| Jun 2014 | - | $2.99 M(-37.3%) |
| Mar 2014 | - | $4.77 M(+56.5%) |
| Dec 2013 | $3.05 M(-38.2%) | $3.05 M(-11.4%) |
| Sep 2013 | - | $3.44 M(-33.1%) |
| Jun 2013 | - | $5.14 M(+142.4%) |
| Mar 2013 | - | $2.12 M(-57.0%) |
| Dec 2012 | $4.93 M(+555.9%) | $4.93 M(-42.8%) |
| Sep 2012 | - | $8.62 M(+610.0%) |
| Jun 2012 | - | $1.21 M(-11.0%) |
| Mar 2012 | - | $1.36 M(+81.5%) |
| Dec 2011 | $751.10 K(+129.3%) | $751.10 K(-58.6%) |
| Sep 2011 | - | $1.81 M(+29.4%) |
| Jun 2011 | - | $1.40 M(+273.6%) |
| Mar 2011 | - | $375.40 K(+14.6%) |
| Dec 2010 | $327.50 K(+504.2%) | $327.50 K(-42.7%) |
| Sep 2010 | - | $571.80 K(-81.7%) |
| Jun 2010 | - | $3.13 M(+4911.7%) |
| Mar 2010 | - | $62.40 K(+15.1%) |
| Dec 2009 | $54.20 K(+24.0%) | $54.20 K(+228.5%) |
| Sep 2009 | - | $16.50 K(-62.2%) |
| Dec 2008 | $43.70 K | $43.70 K |
FAQ
- What is Xtant Medical Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Xtant Medical Holdings?
- What is Xtant Medical Holdings annual cash & cash equivalents year-on-year change?
- What is Xtant Medical Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Xtant Medical Holdings?
- What is Xtant Medical Holdings quarterly cash and cash equivalents year-on-year change?
What is Xtant Medical Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of XTNT is $5.71 M
What is the all time high annual cash & cash equivalents for Xtant Medical Holdings?
Xtant Medical Holdings all-time high annual cash & cash equivalents is $20.30 M
What is Xtant Medical Holdings annual cash & cash equivalents year-on-year change?
Over the past year, XTNT annual cash & cash equivalents has changed by -$14.58 M (-71.84%)
What is Xtant Medical Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of XTNT is $6.60 M
What is the all time high quarterly cash and cash equivalents for Xtant Medical Holdings?
Xtant Medical Holdings all-time high quarterly cash and cash equivalents is $20.31 M
What is Xtant Medical Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, XTNT quarterly cash and cash equivalents has changed by -$2.07 M (-23.87%)